
Kishor Mayekar
Examiner (ID: 18425, Phone: (571)272-1339 , Office: P/1759 )
| Most Active Art Unit | 1795 |
| Art Unit(s) | 1759, 1102, 1741, 1754, 1795, 2741, 1753 |
| Total Applications | 2436 |
| Issued Applications | 1650 |
| Pending Applications | 176 |
| Abandoned Applications | 610 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6329340
[patent_doc_number] => 20020198173
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-26
[patent_title] => '[5-carboxamido or 5-fluoro] - [2\' ,3\' -unsaturated or 3\' -modified] - pyrimidine nucleosides'
[patent_app_type] => new
[patent_app_number] => 10/146779
[patent_app_country] => US
[patent_app_date] => 2002-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8580
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0198/20020198173.pdf
[firstpage_image] =>[orig_patent_app_number] => 10146779
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/146779 | 3,5-difluoro-2,3-didehydropyrimidine nucleosides and methods of treatment therewith | May 14, 2002 | Issued |
| 10/144360 | Antiviral phosphorothioate oligonucleotides | May 12, 2002 | Abandoned |
Array
(
[id] => 672581
[patent_doc_number] => 07091372
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-08-15
[patent_title] => 'Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds'
[patent_app_type] => utility
[patent_app_number] => 10/124135
[patent_app_country] => US
[patent_app_date] => 2002-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37765
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/091/07091372.pdf
[firstpage_image] =>[orig_patent_app_number] => 10124135
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/124135 | Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds | Apr 16, 2002 | Issued |
Array
(
[id] => 1281602
[patent_doc_number] => 06642210
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-11-04
[patent_title] => '2-(N-pyrazolo)adenosines with application as adenosine A2A receptor agonists'
[patent_app_type] => B1
[patent_app_number] => 10/018446
[patent_app_country] => US
[patent_app_date] => 2002-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 14912
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 162
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/642/06642210.pdf
[firstpage_image] =>[orig_patent_app_number] => 10018446
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/018446 | 2-(N-pyrazolo)adenosines with application as adenosine A2A receptor agonists | Apr 11, 2002 | Issued |
Array
(
[id] => 1281577
[patent_doc_number] => 06642206
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-11-04
[patent_title] => 'Monocyclic L-nucleosides, analogs and uses thereof'
[patent_app_type] => B2
[patent_app_number] => 10/120101
[patent_app_country] => US
[patent_app_date] => 2002-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 36414
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/642/06642206.pdf
[firstpage_image] =>[orig_patent_app_number] => 10120101
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/120101 | Monocyclic L-nucleosides, analogs and uses thereof | Apr 8, 2002 | Issued |
Array
(
[id] => 569324
[patent_doc_number] => 07462605
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-12-09
[patent_title] => 'Phosphoramidate compounds and methods of use'
[patent_app_type] => utility
[patent_app_number] => 10/119927
[patent_app_country] => US
[patent_app_date] => 2002-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 12
[patent_no_of_words] => 32143
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 25
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/462/07462605.pdf
[firstpage_image] =>[orig_patent_app_number] => 10119927
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/119927 | Phosphoramidate compounds and methods of use | Apr 8, 2002 | Issued |
Array
(
[id] => 6326712
[patent_doc_number] => 20020197684
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-26
[patent_title] => '2\'-deoxy-2\'-alkylnucleotide containing nucleic acid'
[patent_app_type] => new
[patent_app_number] => 10/104956
[patent_app_country] => US
[patent_app_date] => 2002-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 11529
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20020197684.pdf
[firstpage_image] =>[orig_patent_app_number] => 10104956
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/104956 | 2'-deoxy-2'-alkylnucleotide containing nucleic acid | Mar 20, 2002 | Abandoned |
Array
(
[id] => 6913191
[patent_doc_number] => 20050176949
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-11
[patent_title] => 'Process for preparing N6 substituted aminopurine ribofuranose nucleosides'
[patent_app_type] => utility
[patent_app_number] => 10/471682
[patent_app_country] => US
[patent_app_date] => 2002-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4408
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20050176949.pdf
[firstpage_image] =>[orig_patent_app_number] => 10471682
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/471682 | Process for preparing N6 substituted aminopurine ribofuranose nucleosides | Mar 18, 2002 | Issued |
Array
(
[id] => 6526475
[patent_doc_number] => 20020192683
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-19
[patent_title] => 'Fluorescent cobalamins and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/097646
[patent_app_country] => US
[patent_app_date] => 2002-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 10142
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20020192683.pdf
[firstpage_image] =>[orig_patent_app_number] => 10097646
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/097646 | Fluorescent cobalamins and uses thereof | Mar 14, 2002 | Issued |
Array
(
[id] => 6721331
[patent_doc_number] => 20030055021
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-20
[patent_title] => 'Compounds for the treatment of ischemia'
[patent_app_type] => new
[patent_app_number] => 10/099620
[patent_app_country] => US
[patent_app_date] => 2002-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33780
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0055/20030055021.pdf
[firstpage_image] =>[orig_patent_app_number] => 10099620
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/099620 | Compounds for the treatment of ischemia | Mar 14, 2002 | Abandoned |
Array
(
[id] => 1024807
[patent_doc_number] => 06884789
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-04-26
[patent_title] => 'Linear cyclodextrin copolymers'
[patent_app_type] => utility
[patent_app_number] => 10/097326
[patent_app_country] => US
[patent_app_date] => 2002-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 11424
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/884/06884789.pdf
[firstpage_image] =>[orig_patent_app_number] => 10097326
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/097326 | Linear cyclodextrin copolymers | Mar 14, 2002 | Issued |
Array
(
[id] => 1053066
[patent_doc_number] => 06858393
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-02-22
[patent_title] => 'Chain terminators for DNA synthesis'
[patent_app_type] => utility
[patent_app_number] => 10/098019
[patent_app_country] => US
[patent_app_date] => 2002-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 36
[patent_no_of_words] => 12031
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/858/06858393.pdf
[firstpage_image] =>[orig_patent_app_number] => 10098019
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/098019 | Chain terminators for DNA synthesis | Mar 12, 2002 | Issued |
Array
(
[id] => 6766359
[patent_doc_number] => 20030100759
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-29
[patent_title] => 'Selective anti-viral nucleoside chain terminators'
[patent_app_type] => new
[patent_app_number] => 10/097672
[patent_app_country] => US
[patent_app_date] => 2002-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 7787
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20030100759.pdf
[firstpage_image] =>[orig_patent_app_number] => 10097672
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/097672 | Selective anti-viral nucleoside chain terminators | Mar 12, 2002 | Issued |
Array
(
[id] => 6545370
[patent_doc_number] => 20020137727
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-26
[patent_title] => 'Wet granulation formulation for bisphosphonic acids'
[patent_app_type] => new
[patent_app_number] => 10/090541
[patent_app_country] => US
[patent_app_date] => 2002-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3185
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20020137727.pdf
[firstpage_image] =>[orig_patent_app_number] => 10090541
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/090541 | Wet granulation formulation for bisphosphonic acids | Mar 3, 2002 | Abandoned |
Array
(
[id] => 7336879
[patent_doc_number] => 20040132686
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-08
[patent_title] => 'C2,5\'- disubstituted and N6, c2,5\'- trisubstituted adenosine derivatives and their different uses'
[patent_app_type] => new
[patent_app_number] => 10/469735
[patent_app_country] => US
[patent_app_date] => 2004-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 29447
[patent_no_of_claims] => 75
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0132/20040132686.pdf
[firstpage_image] =>[orig_patent_app_number] => 10469735
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/469735 | C2,5′-disubstituted and N6, C2,5′-trisubstituted adenosine derivatives and their different uses | Mar 2, 2002 | Issued |
Array
(
[id] => 7305972
[patent_doc_number] => 20040116374
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-17
[patent_title] => 'C2, 8-disubstituted adenosine derivatives and their different uses'
[patent_app_type] => new
[patent_app_number] => 10/469645
[patent_app_country] => US
[patent_app_date] => 2004-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14812
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0116/20040116374.pdf
[firstpage_image] =>[orig_patent_app_number] => 10469645
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/469645 | C2,8-disubstituted adenosine derivatives and their different uses | Mar 2, 2002 | Issued |
Array
(
[id] => 6835411
[patent_doc_number] => 20030162957
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-28
[patent_title] => 'Protected deoxyadenosines and deoxyguanosines'
[patent_app_type] => new
[patent_app_number] => 10/083216
[patent_app_country] => US
[patent_app_date] => 2002-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8861
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0162/20030162957.pdf
[firstpage_image] =>[orig_patent_app_number] => 10083216
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/083216 | Protected deoxyadenosines and deoxyguanosines | Feb 25, 2002 | Abandoned |
Array
(
[id] => 6413599
[patent_doc_number] => 20020183314
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-05
[patent_title] => 'Tricyclic quinolinone and tricyclic quinoline androgen receptor modulator compounds and methods'
[patent_app_type] => new
[patent_app_number] => 10/080503
[patent_app_country] => US
[patent_app_date] => 2002-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43392
[patent_no_of_claims] => 107
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20020183314.pdf
[firstpage_image] =>[orig_patent_app_number] => 10080503
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/080503 | Tricyclic quinolinone and tricyclic quinoline androgen receptor modulator compounds and methods | Feb 21, 2002 | Issued |
Array
(
[id] => 6740819
[patent_doc_number] => 20030158188
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-21
[patent_title] => 'Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor'
[patent_app_type] => new
[patent_app_number] => 10/079324
[patent_app_country] => US
[patent_app_date] => 2002-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30406
[patent_no_of_claims] => 68
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20030158188.pdf
[firstpage_image] =>[orig_patent_app_number] => 10079324
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/079324 | Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor | Feb 19, 2002 | Abandoned |
Array
(
[id] => 6442154
[patent_doc_number] => 20020128466
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-12
[patent_title] => 'Method of synthesizing phosphorothioate oligonucleotides'
[patent_app_type] => new
[patent_app_number] => 10/068604
[patent_app_country] => US
[patent_app_date] => 2002-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12576
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0128/20020128466.pdf
[firstpage_image] =>[orig_patent_app_number] => 10068604
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/068604 | Method of synthesizing phosphorothioate oligonucleotides | Feb 5, 2002 | Abandoned |